Soc. Generale Bonus Zert MRK 27.0.../ DE000SV4G3L3 /
24/05/2024 21:37:59 | Chg.-0.100 | Bid21:59:46 | Ask21:59:46 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
188.360EUR | -0.05% | 188.400 Bid Size: 750 |
189.080 Ask Size: 750 |
MERCK KGAA O.N. | - EUR | 27/09/2024 | Call |
GlobeNewswire
24/05
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenaden...
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA